Coping with the grief of a thousand tiny losses
When you or someone you know is suspected of having a rare cancer like myeloma, it is natural to prepare for the worst. You…
Myeloma
Carvykti label updated to include survival benefit data in myeloma
Regulators in the U.S. and Europe have approved updates to the prescribing information for Carvykti (ciltacabtagene autoleucel), a cell therapy …
The caregiver’s inevitable process of unlearning
I am learning to unlearn certain things. Throughout my life, I was taught that if you work hard, you will succeed. I was also taught…
FDA approves 1st treatment for high-risk smoldering myeloma
The U.S. Food and Drug Administration (FDA) has approved Darzalex Faspro (daratumumab and hyaluronidase) for adults with high-risk smoldering multiple myeloma, making it…
When the family caregiver becomes the ‘care-getter’
Women often play the role of caregiver. When our loved ones are sick or hurting, we’re the ones ladling out chicken soup, whether it’s for…
For a myeloma caregiver, being seen is a gift
It happened at the drugstore. My shoulders were tight as I leaned against the counter. It was the fourth time that evening that I was…
Caribou’s CB-011 may be effective, safe for hard-to-treat myeloma
One-time use of CB-011, Caribou Biosciences’ off-the-shelf CAR T-cell therapy candidate, showed a manageable safety profile and resulted in lasting responses in adults with…
When it comes to medical jargon, where’s my secret decoder ring?
I see a lot of jargon in my line of work. A big part of my job is helping reporters translate it into something our…
Learning to reframe the stories we tell ourselves as caregivers
As a caregiver to my mum, who has myeloma, I usually experience some moments of quietness. One of these moments might be when we’re…
Myeloma treatment HDP-101 put on FDA fast track
The U.S. Food and Drug Administration (FDA) has granted fast track designation to HDP-101 (pamlectabart tismanitin), a multiple myeloma therapy currently in early clinical…
